Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
The Fed’s September rate cut turbo-charged the stock market, but can the market keep up its bull run for 2025?
The massive private-equity investments are causing concerns about its impact on the wealth management industry.
New filings with the Securities and Exchange Commission are requesting permission to launch ETFs that hold both public and private assets.